Access the full text.
Sign up today, get DeepDyve free for 14 days.
Yoshimi Fukuoka, W. Haskell, F. Lin, E. Vittinghoff (2019)
Short- and Long-term Effects of a Mobile Phone App in Conjunction With Brief In-Person Counseling on Physical Activity Among Physically Inactive WomenJAMA Network Open, 2
S. Yusuf (2002)
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. CommentaryThe Lancet, 360
J. Armitage, L. Bowman, R. Clarke, K. Wallendszus, R. Bulbulia, K. Rahimi, R. Haynes, S. Parish, P. Sleight, R. Peto, R. Collins (2010)
Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial.JAMA, 303 24
J. Wittes (2002)
Sample size calculations for randomized controlled trials.Epidemiologic reviews, 24 1
Lang (1991)
Estimating the effect of the run-in on the power of the Physicians’ Health Study.Stat Med, 10
J. Sundström, H. Arima, M. Woodward, R. Jackson, Kunal Karmali, D. Lloyd‐Jones, C. Baigent, J. Emberson, K. Rahimi, S. MacMahon, Anushka Patel, V. Perkovic, F. Turnbull, B. Neal (2014)
Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient dataThe Lancet, 384
M. Landray, R. Haynes, J. Hopewell, S. Parish, Theingi Aung, J. Tomson, K. Wallendszus, M. Craig, Lixin Jiang, R. Collins, J. Armitage (2014)
Effects of extended-release niacin with laropiprant in high-risk patients.The New England journal of medicine, 371 3
P. Rothwell (2005)
External validity of randomised controlled trials: “To whom do the results of this trial apply?”The Lancet, 365
J. Lang, Julie Buring, B. Rosner, N. Cook, C. Hennekens (1991)
Estimating the effect of the run-in on the power of the Physicians' Health Study.Statistics in medicine, 10 10
M. Detry, R. Lewis (2014)
The intention-to-treat principle: how to assess the true effect of choosing a medical treatment.JAMA, 312 1
AndrewJ. Coats (2002)
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialThe Lancet, 360
This JAMA Guide to Statistics and Methods reviews the use of prerandomization run-in periods to improve treatment adherence and reduce loss to follow-up, and explains how they should be interpreted.
JAMA – American Medical Association
Published: Jul 14, 2020
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.